Prolonged treatment (18 months) of chronic hepatitis C with recombinant a-interferon in comparison with a control group.

Gómez Rubio M, Porres JC, Castillo I, Quiroga JA, Moreno A,Carreño V. J Hepatol 1990; 11 (S1): s63-s67.